Feature Review,cardiac-derived hormones with a range of protective functions

Natriuretic peptides are a vital group of hormones that play a significant role in regulating the cardiovascular system, body fluid balance, and blood pressure. These proteins that your heart and blood vessels make are secreted primarily by the heart muscle in response to increased volume or pressure. Understanding their function is crucial for diagnosing and managing various cardiovascular conditions, particularly heart failure.

The natriuretic peptide system comprises several key players, including atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). These are a family of three structurally related hormone/paracrine factors, each with distinct but complementary roles. ANP is primarily synthesized and secreted by the atrial myocytes of the heart in response to atrial stretch, often caused by increased blood volume. BNP, on the other hand, is mainly produced by the ventricular myocytes and is released in response to increased ventricular wall stress and volume overload. CNP is found in various tissues, including the endothelium and brain, and is thought to have more local paracrine effects.

The Physiological Functions of Natriuretic Peptides

The primary function of natriuretic peptides is to counteract the effects of the renin-angiotensin-aldosterone system (RAAS), which tends to increase blood pressure and fluid retention. They achieve this through several mechanisms:

* Natriuresis and Diuresis: Natriuretic peptides promote the excretion of sodium (natriuresis) and water (diuresis) by the kidneys. This leads to a reduction in expanded extracellular fluid (ECF) volume, helping to decrease blood volume and pressure.

* Vasodilation: They cause relaxation of vascular smooth muscle, leading to vasodilation. This widening of blood vessels reduces peripheral resistance and lowers blood pressure.

* Inhibition of RAAS: Natriuretic peptides inhibit the release of renin and aldosterone, further reducing sodium and water reabsorption and promoting vasodilation.

* Cardiovascular Remodeling: Recent findings of the cardiovascular effects of NPs highlight their role in modulating cardiac structure and function. They can inhibit detrimental processes like cardiac hypertrophy and fibrosis, thus offering protective effects on the heart.

* Lusitropy: Natriuretic peptides can enhance myocardial relaxation (lusitropy), allowing the heart to fill more effectively during diastole.

Essentially, the net effect of natriuretic peptides is to promote urine excretion, relax blood vessels, lower blood pressure, and reduce the heart's workload. They are hormones that regulate body fluid homeostasis and blood pressure.

Natriuretic Peptides in Heart Failure Diagnosis and Prognosis

One of the most significant clinical applications of natriuretic peptides is in the diagnosis and management of heart failure (HF). When the heart is under stress, such as in heart failure, the ventricles are stretched, leading to increased secretion of BNP and its inactive precursor, N-terminal pro-B-type natriuretic peptide (NT-proBNP).

* Natriuretic peptide tests measure the levels of these peptides in the blood. A B-type natriuretic peptide (BNP) test or NT-proBNP test is a common diagnostic tool.

* High levels of BNP or NT-proBNP in the blood are indicative of elevated cardiac filling pressures and myocardial stretch, making them powerful diagnostic biomarkers for heart failure.

* The natriuretic peptide test is particularly useful in distinguishing between cardiac and non-cardiac causes of dyspnea (shortness of breath). In patients presenting with shortness of breath, a normal or low BNP level makes heart failure unlikely, while an elevated level strongly suggests heart failure as the cause.

* Plasma levels of natriuretic peptides have proven to be powerful diagnostic and prognostic biomarkers of heart disease. Elevated levels are not only indicative of current heart failure but also predict a worse prognosis, including increased risk of hospitalization and mortality.

* The most important use of natriuretic peptides is in helping to establish the diagnosis of heart failure (HF) in a patient in the urgent setting.

Other Clinical Implications and Related Conditions

Beyond heart failure, natriuretic peptides are implicated in other cardiovascular and metabolic conditions.

* Dysregulation of the natriuretic peptide system has been associated with obesity, glucose intolerance, type 2 diabetes mellitus, and essential hypertension. This suggests a broader role in cardiometabolic health.

* Natriuretic peptides can also serve as markers of hemodynamic stress on the heart, denoting the neurohumoral activation of the myocardium.

* While not a primary therapeutic target yet, research into natriuretic peptides and their receptors is ongoing, exploring their potential for novel drug development.

In summary, natriuretic peptides are essential hormones produced by the heart and blood vessels that play a critical role in maintaining cardiovascular homeostasis. Their ability to promote sodium and water excretion, induce vasodilation, and counteract the effects of the RAAS makes them vital